Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Oncology September 27,2024 0

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Oncology September 27,2024 0

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Oncology September 27,2024 0

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Oncology September 27,2024 0

Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Oncology September 27,2024 0

Elle Macpherson says she refused chemotherapy after breast cancer diagnosis—here's what oncologists think

byUniversity of VirginiaCredit: Pixabay/CC0 Public DomainAfter being diagnosed with breast cancer seven years ago, Elle Macpherson made a controversial choice: She refused chemotherapy, the mode

Oncology September 27,2024 0

Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to

Oncology September 27,2024 0

Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to

Oncology September 27,2024 0

Preclinical study finds novel bone cancer therapy has 99% success rate

byAston UniversityProfessor Richard Martin. Credit: Aston UniversityBioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined

Oncology September 27,2024 0

Preclinical study finds novel bone cancer therapy has 99% success rate

byAston UniversityProfessor Richard Martin. Credit: Aston UniversityBioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined

Oncology September 27,2024 0

Pollution exposure may affect lung cancer in women who have never smoked

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainRecent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure may sign

Oncology September 27,2024 0

Pollution exposure may affect lung cancer in women who have never smoked

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainRecent air pollution exposure in the form of particles smaller than 2.5 micrometers (PM2.5) exposure may sign

Oncology September 27,2024 0

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Oncology September 27,2024 0

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Oncology September 27,2024 0

AI tool reveals cardiac risk for patients undergoing cancer therapy

byYale School of MedicineBaseline AI-ECG screening for LVSD and all-cause mortality risk. Adjusted cumulative hazard curves for all-cause mortality stratified by the AI-ECG LVSD probability. Cre

Cardiology & Vascular surgery September 27,2024 0

AI tool reveals cardiac risk for patients undergoing cancer therapy

byYale School of MedicineBaseline AI-ECG screening for LVSD and all-cause mortality risk. Adjusted cumulative hazard curves for all-cause mortality stratified by the AI-ECG LVSD probability. Cre

Cardiology & Vascular surgery September 27,2024 0

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Nephrology & Urology September 27,2024 0

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Nephrology & Urology September 27,2024 0

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Oncology September 27,2024 0

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Oncology September 27,2024 0